newsfilter
← Latest News
PR Newswire·

NLS Pharmaceutics and Kadimastem announce a Hong Kong Patent Covering Cell-Selection and Enrichment Technology for IsletRx for Diabetes Patients

NLS Pharmaceutics Ltd. (Nasdaq: NLSP) ("NLS" or the "Company") today announced that its merger partner Kadimastem Ltd. (TASE: KDST) ("Kadimastem")...